300453SZSE

Announcement on the Results of Issuing Convertible Corporate Bonds to Unspecified Targets

Sanxin Medical Co., Ltd.·August 9, 2026·5 pages

✨ AI Summary

Jiangxi Sanxin Medical & Health Technology Co., Ltd. announced the results of its convertible bond issuance. The total issuance size was RMB 530 million. The company successfully placed 85.24% of the bonds to existing shareholders via priority allocation, with the remaining portion subscribed by online investors and underwritten by the sponsor.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 300453

Securities Abbreviation: Sanxin Medical

Announcement No.: 2026-053

Jiangxi Sanxin Medical & Health Technology Co., Ltd.

Announcement on the Results of Issuing Convertible Corporate Bonds to Unspecified Targets

Sponsor (Lead Underwriter): Guojin Securities Co., Ltd.

The Company and the Board of Directors guarantee the authenticity, accuracy, and completeness of the information disclosed herein, and do not have any false records, misleading statements, or major omissions.

Jiangxi Sanxin Medical & Health Technology Co., Ltd. (hereinafter referred to as the "Issuer") has obtained approval from the China Securities Regulatory Commission (CSRC) (Document No. [2026] 1311) for the issuance of convertible corporate bonds to unspecified targets (hereinafter referred to as "Convertible Bonds"). Guojin Securities Co., Ltd. (hereinafter referred to as the "Sponsor (Lead Underwriter)") is the sponsor (lead underwriter) for this issuance. The Convertible Bonds are abbreviated as "Sanxin Convertible Bonds" and the bond code is "123280".

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.